Capitolis Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Capitolis Advisors’s Portfolio TMO Stock Details TMO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-55,000	Closed	-$27.9M	–	56
2022 Q3	$27.9M	Buy	55,000 +14,504	+36%	+$8.12M	1.98%	18
2022 Q2	$22M	Buy	40,496 +40,000	+8,065%	+$22M	1.15%	27
2022 Q1	$293K	Sell	496 -142,131	-100%	-$81.6M	0.01%	115
2021 Q4	$95.2M	Buy	142,627 +76,970	+117%	+$48.1M	0.57%	41
2021 Q3	$38.6M	Buy	65,657 +25,180	+62%	+$13.8M	0.35%	63
2021 Q2	$20.4M	Buy	40,477 +13,869	+52%	+$6.54M	0.24%	98
2021 Q1	$12.1M	Hold	26,608	–	–	0.21%	106
2020 Q4	$12.4M	Buy	+26,608	New	+$12.5M	0.21%	118

Other funds holding TMO

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Capitolis Advisors's TMO Position: Q4 2022 in Review

Capitolis Advisors sold out of Thermo Fisher Scientific (TMO) in Q4 2022, closing a stake of 55,000 shares — an estimated $27.9M sold.

Capitolis Advisors first reported a position in TMO in Q4 2020 and held it in 8 quarters. The position peaked at $95.2M in Q4 2021. 2,374 funds tracked by Wall St. Rank hold TMO as of Q4 2022.

Capitolis Advisors reported no remaining Thermo Fisher Scientific position as of Q4 2022 after selling out during the quarter.
Capitolis Advisors sold 55,000 Thermo Fisher Scientific shares in Q4 2022, an estimated $27.9M.
Capitolis Advisors first reported a position in Thermo Fisher Scientific in Q4 2020 and held it in 8 quarters.
Capitolis Advisors's Thermo Fisher Scientific position peaked at $95.2M in Q4 2021.
2,374 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q4 2022.

Based on Capitolis Advisors's 13F filing for Q4 2022.